Introduction {#s1}
============

The capacity to convey oxygen (O~2~) from the atmosphere in to mitochondria essentially determines maximal aerobic metabolism in humans ([@B1]--[@B6]). The inherent constitution of the O~2~ transport and utilization chain is asymmetrical, not all steps have the same importance ([@B7], [@B8]). Intracellular biochemical mechanisms that could in theory limit O~2~ utilization are overbuilt in relation to the potential delivery of O~2~ through the circulatory system ([@B2], [@B3], [@B9]). Peak oxygen consumption (VO~2peak~), a hallmark of aerobic capacity elicited by incremental exercise involving more than half of total muscle mass, is mainly determined by the circulatory capacity to deliver O~2~ to working muscle even in the presence of compromised muscle oxidative capacity ([@B5], [@B7], [@B8]). Glaring evidence of the impact of the circulatory system on VO~2peak~ includes conditions such as heart failure (HF), intrinsically linked with impaired cardiac output and thus limited convective O~2~ delivery ([@B2], [@B6]). VO~2peak~ is a strong and independent predictor of survival in HF patients used to determine eligibility for cardiac transplantation ([@B6], [@B10], [@B11]). After diagnosis of HF, survival estimates do not exceed 50% at 5 years ([@B12], [@B13]).

Understanding the physiology of O~2~ delivery and thereby VO~2peak~ in HF may facilitate the identification of target mechanisms and the advent of effective treatments. While classic empirical studies in HF patients support the primary role of impaired cardiac pumping capacity in the limitation of VO~2peak~ ([@B14], [@B15]), a recent paradigm based on theoretical assumptions attribute the main importance to skeletal muscle abnormalities in O~2~ diffusion from capillaries in to mitochondria ([@B16]). Given the radical change of rehabilitation programs implicit in the "skeletal muscle" paradigm, herein we sought to shed light on the foundation of this relatively new tenet in the HF field. In particular, a fundamental aspect will be clarified: the measurement and calculation of O~2~ diffusion in skeletal muscle.

O~2~ Transport Assessment: de facto Measurement of O~2~ Diffusion in Skeletal Muscle {#s2}
====================================================================================

The transport of O~2~ in living organisms follows well-known physical phenomena. O~2~ molecules move via (i) convection, due to the bulk motion of fluids, and (ii) diffusion, spontaneously spreading out from a region of high concentration to a region of low concentration. Along the O~2~ cascade, convection is the mode of O~2~ transport between the atmosphere and the lungs, and between pulmonary capillary blood and tissue microvascular beds, respectively determined by the bulk motion of air and circulating blood. Diffusion of O~2~ mainly occurs from alveoli in to pulmonary capillaries, and from tissue microvascular beds in to mitochondria. With respect to the measurement of O~2~ transport, both convection steps (air-to-lung, blood circulation) can be measured with relatively high accuracy in humans by means of spirometers, air/blood gas analyzers, arterial/venous blood samples and indicator-dilution/ultrasound techniques ([@B17], [@B18]). These well-established research methods may also be used to assess lung O~2~ diffusion. The final O~2~ diffusion step in the skeletal muscle microcirculation, however, cannot yet be directly measured. The level of resolution required to capture O~2~ extraction in microvessels supplying active muscle fibers is beyond reach owing to technical limitations including temporal and spatial constraints ([@B8], [@B19]).

The possibility seemingly exists, nonetheless, to make use of partial measurements and multiple assumptions to deliver a quantitative value for skeletal muscle O~2~ diffusion capacity (DMO~2~) ([@B20]--[@B22]). Notably, in the field of HF ([@B16]), some clinical researchers are currently applying a method for estimating DMO~2~ conceived almost 3 decades ago ([@B20]--[@B22]). Herein, DMO~2~ is portrayed as the ratio of skeletal muscle O~2~ consumption (VO~2~) and O~2~ pressure gradient between microvessels and mitochondria ([@B21], [@B23], [@B24]).
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At first sight the notion of DMO~2~ appears consistent, albeit a close scrutiny of the actual measurements reveals salient incongruences. Skeletal muscle O~2~ consumption---calculated by the product of leg blood flow (LBF) and the difference between femoral arterial and venous O~2~ content ([@B16], [@B21])---is primarily determined by convective O~2~ delivery, since LBF is substantially impaired (up to −40%) in HF conforming to the reduced pumping capacity of the failing heart ([@B6], [@B25]). Moreover, femoral vein O~2~ content is close to zero in HF patients at VO~2peak~ ([@B2]). Therefore, the first component (numerator) of the DMO~2~ equation, i.e., skeletal muscle VO~2~, is essentially a function of convective O~2~ delivery (LBF × arterial O~2~ content) a fundamental mathematical flaw for a variable claimed to represent diffusive O~2~ transport ([Figure 1](#F1){ref-type="fig"}).

![Common schematic illustration of convective and diffusive components of oxygen consumption (VO~2~) by proponents of abnormalities in skeletal muscle O~2~ diffusion. Leg O~2~ consumption is represented as a function of leg microvascular partial pressure of oxygen (PO~2~). Black lines depict Fick and "Diffusion" lines for healthy control individuals; red lines refer to heart failure (HF) patients. The intersection of these lines reflects the VO~2~ achieved (blue circles). Curved lines are derived from the established Fick Principle. Straight "Diffusion" lines are calculated by the product of skeletal muscle O~2~ diffusion capacity (DMO~2~) and O~2~ pressure gradient. Given that DMO~2~ cannot be directly measured, the "Diffusion" lines are intrinsically dependent on VO~2~, which is at least in part determined by cardiac output (Q), i.e., convective O~2~ delivery, according to the Fick Principle. Hence, "Diffusion" lines are compounded representations of convective and diffusive components of VO~2~.](fcvm-06-00078-g0001){#F1}

The O~2~ pressure gradient between skeletal muscle microvessels and mitochondria is also estimated from femoral arterial and venous O~2~ content measurements, both pertaining to the macro- instead of microcirculation ([@B16], [@B21]). A myriad of assumptions are thus necessary to infer the postulated denominator of the DMO~2~ equation ([@B20]). For instance, the inherent heterogeneity of leg microvascular blood flow ([@B26], [@B27]), which even at VO~2peak~ perfuses tissues (e.g., adipose tissue, bone, inactive muscle) not demanding a high VO~2~, is neglected ([@B20], [@B21]). Similarly, altered capillarization as well as anatomical and/or functional shunting within the lower limb, which may have a substantial influence in HF patients at VO~2peak~ ([@B28], [@B29]), is ignored ([@B16], [@B21]). Taken together, the estimation of the O~2~ pressure gradient entails as a necessary premise that all blood flow downstream of the femoral artery perfuses active muscle fibers, in a perfect match between O~2~ delivery and metabolic demand, an untenable shortcoming ([@B26]--[@B28]).

Considering the actual measurements underpinning the concept of DMO~2~, its mathematical equation would be more accurately expressed as: $$\begin{array}{l}
{\text{DMO}_{2}\  = \ \frac{\text{LBF}\  \times \ \text{arteriovenous}\ \text{O}_{2}\ \text{difference}\ }{\text{Blood}\ \text{flow}\ \text{distribution}\  \times \ \text{O}_{2}\ \text{pressure}\ \text{gradient}}} \\
\end{array}$$ Hence, the numerator and denominator of DMO~2~ comprise variables reflecting convective O~2~ delivery, LBF and blood flow distribution, respectively. The observation of reduced DMO~2~ in HF patients is therefore not surprising ([@B16], [@B23], [@B24]). To conclude from these studies that mechanisms underlying skeletal muscle O~2~ diffusion should be primarily targeted for therapy is questionable ([@B30]). Caution should be taken in the interpretation of lower DMO~2~ in HF patients, which can be largely attributed to abnormalities in convective O~2~ delivery, let alone presenting DMO~2~ results as the main buttress of a new paradigm ([@B31], [@B32]). Further research taking advantage of technological developments in measurement accuracy and resolution of O~2~ dynamics in skeletal muscle will have to elucidate its role in the limitation of VO~2peak~ in HF populations.
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